66
Participants
Start Date
May 6, 2015
Primary Completion Date
December 10, 2024
Study Completion Date
December 17, 2024
Bendamustine
Debulking: Cycles 1-2, d1 \& 2: 70mg/m² i.v.
GA101
Induction: Cycle 1: d1: 100mg, d1(or 2): 900mg, d8 \& 15: 1000mg; Cycle 2-6: d1: 1000mg Maintenance: Cycles 1-8 (Duration 12 weeks): d1: 1000mg
ABT-199
Induction: Cycle 2: d1-7: 20mg, d8-14: 50mg, d15-21: 100mg, d22-28: 200mg; Cycle 3-6: d1-28: 400mg Maintenance: Cycles 1-8 (Duration 12 weeks): d1-84: 400mg
German CLL Study Group, Cologne
Collaborators (1)
Hoffmann-La Roche
INDUSTRY
AbbVie
INDUSTRY
German CLL Study Group
OTHER